Available online at: (Accessed January 31, 2025)
The ideal injection sites include the deltoid, the stomach, or the thigh
Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody
IGF-1 metabolic actions are partly directed at stimulating the uptake of glucose, fatty acids, and amino acids so that metabolism supports growing tissues
MT-1 in subcutaneous implant formulation and documented significant increases in pain-free sun exposure time in EPP patients, with studies characterising reduced phototoxic reactions, improved quality of life, and clinically meaningful photoprotection in a patient population where even brief visible light exposure produces severe phototoxic pain
Heard a lot about peptides and the FDA recently